These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32614987)

  • 1. Intradermal injection of incobotulinumtoxinA for face lifting.
    Wanitphakdeedecha R; Nokdhes YN; Patthamalai P; Yan C; Techapichetvanich T; Phothong W; Eimpunth S; Manuskiatti W
    Dermatol Ther; 2020 Nov; 33(6):e13944. PubMed ID: 32614987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparison between intradermal injection of abobotulinumtoxinA and normal saline for face-lifting: a split-face randomized controlled trial.
    Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Rojanavanich V; Phothong W; Manuskiatti W
    J Cosmet Dermatol; 2016 Dec; 15(4):452-457. PubMed ID: 27647769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intradermal Micro-Dosing of AbobotulinumtoxinA for Face-Lifting: How Long Does It Last?
    Wanitphakdeedecha R; Yan C; Apinuntham C; Rojanavanich V; Cembrano KAG; Eimpunth S; Manuskiatti W
    Dermatol Ther (Heidelb); 2020 Aug; 10(4):779-789. PubMed ID: 32591944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Split face comparison between common concentration vs double dilution of intradermal abobotulinum toxin type A (Dysport) injection for facial lifting in Asians.
    Sirithanabadeekul P; Lapsomboonsiri S; Rungjang A; Thanasarnaksorn W
    J Cosmet Dermatol; 2018 Jun; 17(3):355-360. PubMed ID: 29878718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Intradermal Injection of Botulinum Toxin A for Facial Lifting.
    Atwa EM; Nasr MM; Ebrahim HM
    J Clin Aesthet Dermatol; 2020 Dec; 13(12):22-26. PubMed ID: 33488914
    [No Abstract]   [Full Text] [Related]  

  • 6. The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A.
    Chang SP; Tsai HH; Chen WY; Lee WR; Chen PL; Tsai TH
    Int J Dermatol; 2008 Dec; 47(12):1287-94. PubMed ID: 19126019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different injection patterns of incobotulinumtoxinA for crow's feet: a split-face comparative study.
    Vachiramon V; Subpayasarn U; Triyangkulsri K; Jurairattanaporn N; Rattananukrom T
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):256-262. PubMed ID: 33068445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-center, open-label, randomized, split-face study to assess the efficacy and safety of one versus three intradermal injection sites of abobotulinumtoxinA in the treatment of lateral periocular rhytides.
    Fabi SG; Sundaram H; Guiha I; Goldman MP
    J Drugs Dermatol; 2013 Aug; 12(8):932-7. PubMed ID: 23986168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of intradermal injection of type A botulinum toxin for facial rejuvenation.
    Zhu J; Ji X; Xu Y; Liu J; Miao YY; Zhang JA; Luo D; Zhou BR
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27862727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal Microdroplet Injection of Diluted Incobotulinumtoxin-A for Sebum Control, Face Lifting, and Pore Size Improvement.
    Park JY; Cho SI; Hur K; Lee DH
    J Drugs Dermatol; 2021 Jan; 20(1):49-54. PubMed ID: 33400411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Controlled Trial Comparing the Efficacy and Safety of Two Injection Techniques of IncobotulinumtoxinA for Axillary Hyperhidrosis.
    Trindade de Almeida AR; Noriega LF; Bechelli L; Suárez MV
    J Drugs Dermatol; 2020 Jul; 19(7):765-770. PubMed ID: 32726556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of High-Dose Botulinum Toxin Injections for Parotid and Submandibular Gland Radioprotection.
    Mueller J; Langbein T; Mishra A; Baum RP
    Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, Tolerability, and Efficacy of Repeat-Dose Injections of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results from a Prospective, Open-Label, Phase III Study.
    Fischer T; Sattler G; Prager W; Rzany B; Pavicic T; Gauglitz G; Weissenberger P; Riaz S
    J Drugs Dermatol; 2020 May; 19(5):461-469. PubMed ID: 32484631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the abobotulinumtoxinA with different dilution on the treatment of the upper face.
    Güvenç U; Kutlu Ö; Prof ÜT
    Dermatol Ther; 2020 Nov; 33(6):e13850. PubMed ID: 32543767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single-blind, Split-face, Randomized, Pilot Study Comparing the Effects of Intradermal and Intramuscular Injection of Two Commercially Available Botulinum Toxin A Formulas to Reduce Signs of Facial Aging.
    Sapra P; Demay S; Sapra S; Khanna J; Mraud K; Bonadonna J
    J Clin Aesthet Dermatol; 2017 Feb; 10(2):34-44. PubMed ID: 28367260
    [No Abstract]   [Full Text] [Related]  

  • 16. Employing microbotox technique for facial rejuvenation and face-lift.
    Iranmanesh B; Khalili M; Mohammadi S; Amiri R; Aflatoonian M
    J Cosmet Dermatol; 2022 Oct; 21(10):4160-4170. PubMed ID: 35064633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel combination regimen with intense focused ultrasound and pressure- and dose-controlled transcutaneous pneumatic injection of hypertonic glucose solution for lifting and tightening of the aging face.
    Kwon HH; Choi SC; Park KH; Jung JY
    J Cosmet Dermatol; 2018 Jun; 17(3):373-379. PubMed ID: 29024489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are There Differences Between Intradermal and Intramuscular Injections of Botulinum Toxin on the Forehead?
    Kim YJ; Lim OK; Choi WJ
    Dermatol Surg; 2020 Dec; 46(12):e126-e131. PubMed ID: 32205751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Study on the Duration and Efficacy of Various Botulinum Toxin Type A Injections for Reducing Masseteric Muscle Bite Force and Treating Facial Wrinkles.
    Sirisuthivoranunt S; Wongdama S; Phumariyapong P; Nokdhes YN; Thongjaroensirikul P; Techapichetvanich T; Pettersson M; Ågren M; Wanitphakdeedecha R
    Dermatol Ther (Heidelb); 2024 May; 14(5):1315-1325. PubMed ID: 38724840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective, Neurophysiologic Comparative Study to Assess the Efficacy and Duration of Effect of IncobotulinumtoxinA and AbobotulinumtoxinA in the Treatment of Crow's Feet.
    Saybel A; Artemenko A; Nikitin S; Kurenkov A
    J Drugs Dermatol; 2015 Nov; 14(11):1291-6. PubMed ID: 26580879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.